Back to search
FDAFDA · Food and drugs·Recall number D-0166-2021

Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920 NDC 13668-462-01

Published December 9, 2020 · Recall initiated: November 25, 2020

Summary

FDA records drug Class I recall D-0166-2021, published December 9, 2020 and initiated November 25, 2020. Recalling firm: Torrent Pharma Inc; Status: Terminated; Reported quantity: 2496 Bottles; Lot: Batch BFD1G001, exp 12/2021. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if ANAGRELIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ANAGRELIDE
Manufacturer
Torrent Pharma Inc
Distributor
Nationwide USA and Puerto Rico
Lot
Batch BFD1G001, exp 12/2021
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920 NDC 13668-462-01 recalled?

Yes. FDA published recall D-0166-2021 on December 9, 2020. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ANAGRELIDE.